2010The Chinese Journal of Modern Applied PharmacyRequires access

Study on Pharmacokinetics and Bioequivalence of Azithromycin Dispersible Tablets in Healthy Volunteers

Yuqing Xiong

Open publisher page 0 citations

Abstract

OBJETIVE To study the pharmacokinetics and bioequivalence of azithromycin dispersible tablets in healthy volunteers.METHODS A single oral dose of 500 mg test or reference formulations was given to 20 male healthy volunteers in a randomized cross-over design.The concentration of azithromycin in plasma was determined by HPLC-MS.Pharmacokinetic parameters and relative bioavailability were calculated by DAS 2.0 software.RESULTS The main pharmacokinetic parameters of test and reference azithromycin were as the followings:AUC0-168(8.98±1.74) μg·h·mL-1 and(8.75±1.60) μg·h·mL-1;Cmax(0.81±0.14) μg·mL-1 and(0.80±0.14) μg·h·mL-1;t1/2(48.16±11.10) h and(51.1±7.60) h;Tmax(1.80±0.86) h and(1.82±0.92) h.The relative bioavailability of test to reference preparation was(103.4±20.2)%.CONCLUSION The test and reference formulations were bioequivalent.

About this research paper

What this paper is about

OBJETIVE To study the pharmacokinetics and bioequivalence of azithromycin dispersible tablets in healthy volunteers.METHODS A single oral dose of 500 mg test or reference formulations was given to 20 male healthy volunteers in a randomized cross-over design.The concentration of azithromycin in plasma was determined by HPLC-MS.Pharmacokinetic parameters and relative bioavailability were calculated by DAS 2.0 software.RESULTS The main pharmacokinetic parameters of test and reference azithromycin were as the followings:AUC0-168(8.98±1.74) μg·h·mL-1 and(8.75±1.60) μg·h·mL-1;Cmax(0.81±0.14) μg·mL-1 and(0.80±0.14) μg·h·mL-1;t1/2(48.16±11.10) h and(51.1±7.60) h;Tmax(1.80±0.86) h and(1.82±0.92) h.The relative bioavailability of test to reference preparation was(103.4±20.2)%.CONCLUSION The test and reference formulations were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJETIVE To study the pharmacokinetics and bioequivalence of azithromycin dispersible tablets in healthy volunteers.METHODS A single oral dose of 500 mg test or reference formulations was given to 20 male healthy volunteers in a randomized cross-over design.The concentration of azithromycin in plasma was determined by HPLC-MS.Pharmacokinetic parameters and relative bioavailability were calculated by DAS 2.0 software.RESULTS The main pharmacokinetic parameters of test and reference azithromycin were as the followings:AUC0-168(8.98±1.74) μg·h·mL-1 and(8.75±1.60) μg·h·mL-1;Cmax(0.81±0.14) μg·mL-1 and(0.80±0.14) μg·h·mL-1;t1/2(48.16±11.10) h and(51.1±7.60) h;Tmax(1.80±0.86) h and(1.82±0.92) h.The relative bioavailability of test to reference preparation was(103.4±20.2)%.CONCLUSION The test and reference formulations were bioequivalent.

Key concepts: Bioequivalence, Azithromycin, Pharmacokinetics, Bioavailability, Cmax, Pharmacology, Medicine, Plasma concentration

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on Pharmacokinetics and Bioequivalence of Azithromycin Dispersible Tablets in Healthy Volunteers — Research Paper | ScholarLens